Circulating Extracellular Vesicles in the Pathogenesis of Heart Failure in Patients With Chronic Kidney Disease
Zirkulierende extrazelluläre Vesikel bei der Pathogenese der Herzinsuffizienz bei Patient:innen mit chronischer Nierenerkrankung
Circulation · 13.01.2026 · 153 (2) · 94-114
DOI: 10.1161/circulationaha.125.075579 ↗Auf einen Blick
In einer Querschnittsstudie waren extrazelluläre Vesikel aus dem Plasma von Patient:innen mit CKD kardiotoxisch und beeinträchtigten die Herzfunktion. Ihre Entfernung verbesserte im Mausmodell die Herzfunktion.
Fragestellung
Wie tragen zirkulierende extrazelluläre Vesikel bei CKD zur pathologischen Nieren-Herz-Kommunikation und zur Herzinsuffizienzprogression bei?
Methode
Querschnittsstudie mit Untersuchungen an Patient:innen mit CKD und adeninhaltigem CKD-Mausmodell; Analyse von EVs, miRNA-Sequenzierung und Funktionstests an Kardiomyozyten.
Ergebnisse
EVs aus dem Plasma von Patient:innen mit CKD, nicht von gesunden Kontrollen, induzierten Apoptose in vitro und in vivo und verschlechterten die Kontraktilität. CKD-EV-miRNA-Mimetika waren ebenfalls kardiotoxisch.
Schlussfolgerung der Autor:innen
Die Autor:innen schlussfolgern, dass zirkulierende CKD-EVs mit renalen miRNAs die molekulare Kommunikation zwischen Niere und Herz vermitteln und zur Pathogenese der Herzinsuffizienz bei CKD beitragen.
Kernaussagen
- EVs aus CKD-Plasma waren kardiotoxisch, aus Kontrollen nicht.
- EV-Entfernung verbesserte die Herzfunktion im Mausmodell.
- CKD-EV-miRNAs korrelierten mit Markern kardialer Schädigung.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 13.01.2026. Verfasst von Xisheng Li und 17 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Institute (X.L., N.R., A.G., S.Z., S.L.S., S.Y., A.P., A.S., S.S.), Icahn School of Medicine at Mount Sinai, New York, NY. Hauptthemen laut MEDLINE: Extracellular Vesicles, Heart Failure, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, National Institute of Health.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
BACKGROUND: Cardiovascular disease causes >50% of deaths in patients with advanced chronic kidney disease (CKD). Clinical studies suggest that kidney-derived factors contribute to cardiovascular disease development in CKD, independently of comorbidities. However, to date, no kidney-specific humoral risk factor that triggers direct cardiotoxicity has been identified. In this cross-sectional study, we investigate how, in patients with CKD, circulating extracellular vesicles (EVs) facilitate pathological kidney-heart communication, thereby causing cardiotoxicity, impairing cardiac function, and contributing to heart failure progression. METHODS: We investigated the function of EVs from patients with CKD and adenine diet–induced CKD mice on cardiomyocyte and cardiac contractility. microRNA (miRNA) cargo of EVs was identified by small RNA sequencing and quantitative reverse transcription polymerase chain reaction, and their cardiotoxicity was tested by using miRNA mimics. Tissue and cellular origin of CKD-EV-miRNAs were determined from their corresponding primary miRNA expressions in mice. RESULTS: EVs from plasma of patients with CKD, but not from healthy controls, were cardiotoxic; they significantly induced apoptosis both in vitro and in vivo and impaired contractility of adult rat primary cardiomyocytes in vitro. Likewise, EVs from both plasma and kidneys of CKD mice were cardiotoxic. Pharmacologically depleting circulating EVs in CKD mice significantly recovered cardiac function and ameliorated heart failure, improvements that suggest CKD-EVs play a causal role in heart failure pathogenesis. Both human and mouse CKD-EVs were enriched in distinct miRNAs compared with control EVs. CKD-EV-miRNA mimics were cardiotoxic, impairing contractility and downregulating contractile gene expression in human induced pluripotent stem cell–derived cardiomyocytes. It is interesting that levels of endogenous primary miRNAs corresponding to circulating CKD-EV-miRNAs were significantly higher in CKD kidney tissues, specifically in CD45 -ve CD31 -ve renal cells, but not in CKD hearts, CKD livers, or CKD-peripheral blood mononuclear cells, a result that indicates CKD-EV-miRNAs originate renally. It is remarkable that CKD-EV-miRNA levels correlated with established markers of cardiac injury, thus uncovering the presence of subclinical heart disease and demonstrating heterogeneity in reno-cardiac disease. CONCLUSIONS: Collectively, our human subject and mouse studies show that circulating CKD-EVs, carrying distinct renal-derived miRNAs, mediate the molecular crosstalk that contributes to the pathogenesis of heart failure in CKD. Consequently, CKD-EVs hold promise as diagnostic and prognostic biomarkers for early disease detection and as targets for novel therapeutic interventions in chronic reno-cardiac disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Research Institute (X.L., N.R., A.G., S.Z., S.L.S., S.Y., A.P., A.S., S.S.), Icahn School of Medicine at Mount Sinai, New York, NY.
- Department of Medicine, Cardiology (C.G.S.-G.), Icahn School of Medicine at Mount Sinai, New York, NY.
- Division of Nephrology, University of Virginia, Charlottesville (H.Y., M.H., U.E.).
- Department of Genetics and Genomic Sciences (D.S.), Icahn School of Medicine at Mount Sinai, New York, NY.
- Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease (C.J.L.), Icahn School of Medicine at Mount Sinai, New York, NY.
- Department of Translational Research & Cellular Therapeutics, City of Hope, Los Angeles, CA (R.V.).
ORCID-Profile: Xisheng Li, Alex Gallinat, Carlos G Santos-Gallego, Shihong Zhang, Seonghun Yoon, Hayrettin Yavuz, Anh Phan, David Sachs, Carol J Levy, Navneet Dogra, Susmita Sahoo
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- National Institute of Health
- Breakthrough T1D
Zitieren
APA
Li, X., Raisinghani, N., Gallinat, A., Santos-Gallego, C. G., Zhang, S., La Salvia, S., Yoon, S., Yavuz, H., Phan, A., Shao, A., Harding, M., Sachs, D., Levy, C. J., Dogra, N., Vasavada, R., Dubois, N. C., Erdbrügger, U., & Sahoo, S. (2026). Circulating Extracellular Vesicles in the Pathogenesis of Heart Failure in Patients With Chronic Kidney Disease. Circulation, 153(2), 94-114. https://doi.org/10.1161/circulationaha.125.075579
Vancouver
Li X, Raisinghani N, Gallinat A, Santos-Gallego CG, Zhang S, La Salvia S, et al. Circulating Extracellular Vesicles in the Pathogenesis of Heart Failure in Patients With Chronic Kidney Disease. Circulation. 2026;153(2):94-114. doi:10.1161/circulationaha.125.075579
BibTeX
@article{Li2026,
author = {Li, Xisheng and Raisinghani, Nikhil and Gallinat, Alex and Santos-Gallego, Carlos G and Zhang, Shihong and La Salvia, Sabrina and Yoon, Seonghun and Yavuz, Hayrettin and Phan, Anh and Shao, Alan and Harding, Michael and Sachs, David and Levy, Carol J and Dogra, Navneet and Vasavada, Rupangi and Dubois, Nicole C and Erdbrügger, Uta and Sahoo, Susmita},
title = {Circulating Extracellular Vesicles in the Pathogenesis of Heart Failure in Patients With Chronic Kidney Disease},
journal = {Circulation},
year = {2026},
volume = {153},
number = {2},
pages = {94--114},
doi = {10.1161/circulationaha.125.075579}
}
EUVIMED